Table 2—

Pregnancy outcomes in women with IGT and NGT

VariablesNGT (N = 302) % (n)IGT (N = 102) % (n)P§
EPH syndrome*6.62 (20)19.6 (20)0.0001
Mild or moderate6.62 (20)16.7 (17)0.0024
Preeclampsia and eclampsia0.00 (0)2.94 (3)0.0157
P-ROM1.99 (6)13.7 (14)<0.0001
Breech presentation3.31 (10)10.8 (11)0.0033
Vertex presentation96.4 (291)89.2 (91)0.0060
Preterm birth (<37 gestational weeks)1.32 (4)7.84 (8)0.0026
Caesarean delivery65.9 (199)73.5 (75)0.1535
 Cephalopelvic disproportion33.4 (101)23.5 (24)0.0611
 Breech3.64 (11)8.82 (9)0.0370
 Foetal distress13.6 (41)11.8 (12)0.6394
 Postdates1.96 (2)0.00 (0)0.0633
 Others22.9 (69)46.1 (47)<0.0001
Birth trauma or dystocia0.00 (0)0.00 (0)
Fetal male gender52.3 (158)54.9 (56)0.6512
Birth weight ≥90th percentile13.3 (40)21.6 (22)0.0437
Birth weight ≥95th percentile5.96 (18)12.8 (13)0.0260
Low birth weight (<2,500 g)1.66 (5)1.96 (2)1.0000
Apgar score at 1 min ≤70.99 (3)1.96 (2)0.6039
Hypoglycemia0.33 (1)0.98 (1)0.4417
Pneumonia0.00 (0)1.96 (2)0.0633
Perinatal death0.66 (2)1.96 (2)0.2654
  • *

    * Mild EPH syndrome is SBP/DBP >173/12 kPa (130/90 mmHg), or with an increase in blood pressure of 4/2 kPa (30/15 mmHg) compared with basal blood pressures, that may be accompanied with moderate proteinuria and edema. Moderate EPH syndrome: increase in blood pressure, SBP/DBP > 21.3/14.6 kPa (160/110 mmHg), proteinuria with +, or accompanied with edema or mild symptoms. Severe EPH syndrome includes pre-eclampsia and eclampsia;

  • capillary blood glucose level <1.7 mmol/l;

  • fetal/neonatal death from 28 gestational weeks to 7 days after birth;

  • §

    § χ2 test;

  • Fisher’s exact test.